A nurse wearing personal protective equipment (PPE) picks up a recovered patient of the coronavirus at a hotel designated to treat asymptomatic patients in Karawaci, Indonesia's Banten province. On Tuesday (Oct 6), Indonesia reported their Covid-19 total is above 311,000. - AFP
JAKARTA, Oct 6 (The Jakarta Post/ANN): Indonesia's Food and Drug Monitoring Agency (BPOM) has issued emergency use authorisation (EUA) for two antiviral drugs, favipiravir and remdesivir, to treat COVID-19 patients.
The BPOM also granted permits in September to several pharmaceutical companies to produce the drugs. PT Beta Pharmacon (Dexa Group) received a permit to produce favipiravir, locally sold under the Avigan brand.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
